10-Q: TerrAscend Corp. Reports Q3 2024 Results, Revenue Declines Amidst Strategic Refinancing

Sentiment:

Quarterly Report


TerrAscend Corp. reported a decrease in revenue for the third quarter of 2024, alongside a strategic refinancing effort to address debt obligations.

Worse than expectedThe company's revenue decreased by 17% compared to the same quarter last year.The company's net loss from continuing operations increased significantly compared to the same quarter last year.The company's cost of sales as a percentage of revenue increased, indicating lower profitability.

Summary

  • TerrAscend Corp. experienced a 17% decrease in revenue, falling to $74.2 million in Q3 2024 compared to $89.2 million in Q3 2023, primarily due to reduced retail sales in Michigan and New Jersey.
  • The company's cost of sales decreased by 8% to $38 million, but as a percentage of revenue, it increased to 51% due to lower sales and higher input costs.
  • General and administrative expenses rose by 8% to $31.6 million, mainly due to a one-time stock-based compensation adjustment.
  • Net loss from continuing operations was $21.4 million, compared to a net loss of $8.4 million in the same quarter of the previous year.
  • The company completed a significant refinancing, securing a four-year $140 million senior secured term loan to retire existing debt.
  • As of September 30, 2024, the company had $205.7 million in loans payable, with $8.4 million due within the next twelve months.
  • The company repurchased 107,400 common shares for $133 thousand under a share repurchase program.
  • The company's effective tax rate was a negative 204% for the three months ended September 30, 2024.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company has successfully refinanced its debt, the significant revenue decline and increased net loss raise concerns about its financial health and future performance. The sentiment is therefore negative.

Positives

  • The company successfully refinanced a significant portion of its debt, securing a four-year $140 million senior secured term loan.
  • The company has implemented a share repurchase program, indicating a potential belief in the company's value.
  • The company has addressed going concern issues by refinancing its loans.

Negatives

  • The company experienced a significant decrease in revenue of 17% in Q3 2024 compared to Q3 2023.
  • The cost of sales as a percentage of revenue increased, indicating lower profitability.
  • The company reported a net loss from continuing operations of $21.4 million, a significant increase from the previous year.
  • The company recorded a loss on extinguishment of debt of $1.7 million.
  • The company's effective tax rate was a negative 204% for the three months ended September 30, 2024.

Risks

  • The company faces competitive pressures in the cannabis market, particularly in Michigan and New Jersey.
  • The company's profitability is impacted by higher input costs and lower sales.
  • The company's future performance is subject to regulatory changes and market conditions.
  • The company has a significant amount of debt, with $8.4 million due within the next twelve months.

Future Outlook

The company's future performance is subject to regulatory changes and market conditions, and the company expects to fund future requirements through cash from operations, market offerings, additional debt, sale of real property, sale leaseback transactions, and exercise of options and warrants.

Industry Context

The cannabis industry is facing increased competition and regulatory challenges, which are impacting the company's revenue and profitability. The company's strategic refinancing is a response to these challenges, aiming to improve its financial stability.

Comparison to Industry Standards

  • The company's revenue decline is concerning compared to other cannabis companies that have shown growth in recent quarters.
  • The increase in cost of sales as a percentage of revenue is higher than industry benchmarks, indicating potential inefficiencies.
  • The company's net loss is significant compared to some of its peers, highlighting the need for improved profitability.
  • The company's debt levels are high compared to some of its competitors, but the recent refinancing may improve its financial position.

Legal Proceedings

  • A lawsuit filed by AEY Capital LLC against Pure X, LLC was settled and dismissed with prejudice on June 28, 2024.

Related Party Transactions

  • A related person, who is a key stakeholder of the company, participated in the FG Loan, which makes up $5.5 million of the total loan principal balance at September 30, 2024.

Stakeholder Impact

  • Shareholders may be concerned about the decrease in revenue and increased net loss.
  • Employees may be affected by potential cost-cutting measures.
  • Customers may experience changes in product availability or pricing.
  • Creditors may be reassured by the company's refinancing efforts.

Next Steps

  • The company will continue to execute its strategic plan, focusing on improving operational efficiency and profitability.
  • The company will monitor market conditions and regulatory changes to adapt its business strategy.
  • The company will continue to evaluate opportunities for growth and expansion.

Key Dates

DateDescription
March 7, 2017TerrAscend Corp. was incorporated under the Business Corporations Act (Ontario).
December 18, 2020WDB Holding PA, a subsidiary of TerrAscend, entered into a senior secured term loan with a syndicate of lenders in the amount of $120,000 (Ilera Term Loan).
March 10, 2022The company completed the Gage Acquisition.
October 11, 2022Subsidiaries of TerrAscend entered into a loan agreement with Pelorus Fund REIT, LLC for a single-draw senior secured term loan (the Pelorus Term Loan) in an aggregate principal amount of $45,478.
June 26, 2023The company closed on a $25,000 commercial loan with Stearns Bank.
July 4, 2023The Common Shares commenced trading on the TSX under the ticker symbol 'TSND'.
August 1, 2024The company entered into a Loan Agreement (the FG Loan) for a four-year, $140,000 senior-secured term loan.
August 20, 2024The Board approved a share repurchase program.
September 30, 2024The company had 292,286,858 common shares outstanding.
October 1, 2024The company paid the outstanding principal amount of the Stadium Ventures Note of $539 and retired the promissory note.
October 15, 2024The statute of limitations for the company's 2020 amended tax returns expired.
November 5, 2024The company signed a definitive agreement providing it the option to acquire the assets of Ratio Cannabis LLC.

Keywords

cannabis, refinancing, revenue, debt, net loss, share repurchase, loans, EBITDA, operating expenses, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.